Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

MusclePharm Corporation MSLP

Set alert

Price alert · MSLP

All alert types
0.00 0.00 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
0
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
—
High
—
Earnings
Dec 19, 2022

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for MSLP has not been loaded yet. Try again in a moment.

Valuation

P/E -1.2×
FY 2012: -0.0×FY 2013: -0.2×FY 2014: -0.3×FY 2015: -0.1×FY 2016: -1.5×FY 2017: -0.5×FY 2018: -0.5×FY 2019: -0.4×FY 2020: 4.9×FY 2021: -1.2×
FY 2012 5y median -0.5× FY 2021
P/S 0.3×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.2×FY 2021: 0.3×
FY 2012 5y median 0.1× FY 2021
P/B -0.5×
FY 2012: -0.1×FY 2013: 0.1×FY 2014: 0.2×FY 2015: -0.5×FY 2016: -1.0×FY 2017: -0.4×FY 2018: -0.2×FY 2019: -0.3×FY 2020: -0.6×FY 2021: -0.5×
FY 2012 5y median -0.4× FY 2021
P/FCF -1.9×
FY 2012: -0.3×FY 2013: -0.2×FY 2014: -0.5×FY 2015: 1.8×FY 2016: -0.3×FY 2017: -1.0×FY 2018: 3.1×FY 2019: -1.2×FY 2020: -17.9×FY 2021: -1.9×
FY 2012 5y median -1.2× FY 2021
EV/EBITDA -4.5×
FY 2012: -0.6×FY 2013: 0.0×FY 2014: -1.0×FY 2015: -0.2×FY 2016: 31.7×FY 2017: -3.4×FY 2018: -4.0×FY 2019: -1.2×FY 2020: 4.7×FY 2021: -4.5×
FY 2012 5y median -3.4× FY 2021
EV/Sales 0.5×
FY 2012: 0.1×FY 2013: -0.0×FY 2014: 0.1×FY 2015: 0.1×FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.4×FY 2021: 0.5×
FY 2012 5y median 0.3× FY 2021
FCF Yield -51.4%
FY 2012: -292.6%FY 2013: -434.7%FY 2014: -207.5%FY 2015: 56.1%FY 2016: -305.0%FY 2017: -98.0%FY 2018: 32.4%FY 2019: -84.0%FY 2020: -5.6%FY 2021: -51.4%
FY 2012 5y median -51.4% FY 2021

Profitability

Gross Margin 10.7%
FY 2012: 21.4%FY 2013: 29.9%FY 2014: 31.6%FY 2015: 34.1%FY 2016: 33.6%FY 2017: 29.8%FY 2018: 20.9%FY 2019: 10.9%FY 2020: 30.4%FY 2021: 10.7%
FY 2012 5y median 20.9% FY 2021
Operating Margin -14.8%
FY 2012: -17.3%FY 2013: -15.2%FY 2014: -7.7%FY 2015: -30.5%FY 2016: -1.1%FY 2017: -7.4%FY 2018: -7.8%FY 2019: -18.9%FY 2020: 7.5%FY 2021: -14.8%
FY 2012 5y median -7.8% FY 2021
Net Margin -25.7%
FY 2012: -39.2%FY 2013: -16.0%FY 2014: -7.8%FY 2015: -31.1%FY 2016: -2.6%FY 2017: -10.7%FY 2018: -12.2%FY 2019: -23.8%FY 2020: 4.9%FY 2021: -25.7%
FY 2012 5y median -12.2% FY 2021
ROE 40.0%
FY 2012: 269.4%FY 2013: -89.8%FY 2014: -59.2%FY 2015: 515.1%FY 2016: 71.3%FY 2017: 87.5%FY 2018: 38.1%FY 2019: 67.7%FY 2020: -13.0%FY 2021: 40.0%
FY 2012 5y median 40.0% FY 2021
ROIC 38.6%
FY 2012: 119.1%FY 2013: -75.5%FY 2014: -43.1%FY 2015: 10054.0%FY 2016: -12.5%FY 2017: -90.7%FY 2018: 24.5%FY 2019: 88.4%FY 2020: -58.6%FY 2021: 38.6%
FY 2012 5y median 24.5% FY 2021
ROA -114.9%
FY 2012: -388.5%FY 2013: -34.0%FY 2014: -20.8%FY 2015: -81.3%FY 2016: -10.2%FY 2017: -32.4%FY 2018: -43.7%FY 2019: -130.2%FY 2020: 24.5%FY 2021: -114.9%
FY 2012 5y median -43.7% FY 2021

Growth (YoY)

Revenue -22.3%
FY 2012: 221.8%FY 2013: 65.4%FY 2014: 60.0%FY 2015: -5.9%FY 2016: -20.6%FY 2017: -22.9%FY 2018: -13.7%FY 2019: -9.6%FY 2020: -19.1%FY 2021: -22.3%
FY 2012 FY 2021
Operating Income -252.2%
FY 2012: 40.6%FY 2013: -44.8%FY 2014: 19.2%FY 2015: -274.9%FY 2016: 97.0%FY 2017: -399.0%FY 2018: 9.4%FY 2019: -120.1%FY 2020: 132.2%FY 2021: -252.2%
FY 2012 FY 2021
EPS (diluted) -500.5%
FY 2012: 77.6%FY 2013: 86.3%FY 2014: 49.2%FY 2015: -204.8%FY 2016: 93.2%FY 2017: -203.8%FY 2018: 8.9%FY 2019: -27.8%FY 2020: 108.4%FY 2021: -500.5%
FY 2012 FY 2021
Free Cash Flow -822.5%
FY 2012: 75.6%FY 2013: -632.8%FY 2014: 26.6%FY 2015: 133.3%FY 2016: -636.5%FY 2017: 66.8%FY 2018: 135.8%FY 2019: -453.5%FY 2020: 86.7%FY 2021: -822.5%
FY 2012 FY 2021

Financial Health

Current Ratio 0.3×
FY 2012: 0.3×FY 2013: 1.4×FY 2014: 1.1×FY 2015: 0.7×FY 2016: 0.7×FY 2017: 1.1×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.4×FY 2021: 0.3×
FY 2012 5y median 0.4× FY 2021
Quick Ratio 0.2×
FY 2012: 0.3×FY 2013: 0.9×FY 2014: 0.6×FY 2015: 0.5×FY 2016: 0.5×FY 2017: 0.8×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 0.3×FY 2021: 0.2×
FY 2012 5y median 0.2× FY 2021
Debt / Equity -0.3×
FY 2012: -0.5×FY 2013: 0.1×FY 2014: 0.3×FY 2015: -1.2×FY 2016: -3.9×FY 2017: -2.0×FY 2018: -0.7×FY 2019: -0.4×FY 2020: -0.5×FY 2021: -0.3×
FY 2012 5y median -0.5× FY 2021
Net Debt / EBITDA -1.7×
FY 2012: -0.5×FY 2013: 0.2×FY 2014: -0.6×FY 2015: -0.1×FY 2016: 23.3×FY 2017: -2.6×FY 2018: -3.1×FY 2019: -0.7×FY 2020: 1.8×FY 2021: -1.7×
FY 2012 5y median -1.7× FY 2021
Interest Coverage -1.4×
FY 2012: -1.6×FY 2013: -21.5×FY 2014: -67.7×FY 2015: -65.4×FY 2016: -0.9×FY 2017: -2.3×FY 2018: -1.8×FY 2019: -4.0×FY 2020: 2.9×FY 2021: -1.4×
FY 2012 5y median -1.8× FY 2021

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31